PacWest to buy First California for $231M
Los Angeles-based PacWest Bancorp is buying First California Financial Group for $231 million in an all-stock deal. At $8 per share, PacWest’s price represents an 18.5 percent premium over First California’s share price at the close on Nov. 6. The deal also comes after months of tense negotiations between the rival banks. PacWest offered $7.25 Read More →
Move buys Relocation.com for $11.5M
Online real estate company Move has purchased Relocation.com, a marketplace for homebuyers, renters and moving and storage professionals, for $11.5 million in cash. Move, which also operates Realtor.com and Move.com, said the deal represents another step towards its ultimate goal of creating a one-stop online shop for home buyers and renters. “Our goal is to Read More →
Heritage Oaks to buy Morro Bay branch from Coast National
Paso Robles-based Heritage Oaks Bank is buying the Morro Bay branch and assets of San Luis Obispo-based Coast National Bank. The acquisition, announced Oct. 1, will include about $30 million in deposit accounts. It will also include the branch building. Heritage Oaks said it will pay “market value” for the building at 898 Morro Bay Read More →
Dole sells canned food business to Itochu for $1.7B
Produce giant Dole Food Co. sold its worldwide canned food business to Japanese conglomerate Itochu Corp. on Tuesday, fetching $1.7 billion and marking the Westlake Village-based firm’s exit from Asia. Proceeds from the all-cash sale, the biggest in Dole history, will be used to pay down debt, Dole said. Tokyo-based Itochu now has exclusive rights Read More →
CalAmp signs $25M contract
Oxnard-based wireless products maker CalAmp Corp. has signed a $25 million contract with Navman Wireless for fleet-tracking products. CalAmp said May 7 that under the five-year deal, it has purchased several products and technologies from Navman and set up a research and development center in New Zealand that is staffed by 14 employees brought over Read More →
Amgen, AstraZeneca strike drug development deal
Amgen has entered a development deal with London-based AstraZeneca to jointly commercialize five anti-inflammation drugs. Under the terms of the agreement announced April 2, AstraZeneca will pay a one-time $50 million payment to Amgen and will be responsible for helping the Thousand Oaks-based biotech giant commercialize its inflammation drug pipeline. The firms said in a Read More →